Detection of IL-36? through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema - 06/09/18
![](/templates/common/images/mail.png)
Supported mainly by a 2014 Pfizer Inflammation Competitive Research Programme (ICRP). In addition, assay development support was received by MRC grant MR/M01942X/1. G.D.B. and D.M.R. were funded by the Wellcome Trust (102705, 97377), the MRC Centre for Medical Mycology, and the University of Aberdeen (MR/N006364/1). Some of the samples included in the AD comparator group were acquired in the context of the National Institute for Health Research (NIHR)–funded ALPHA trial (EUDRACT 2014-004741-27) Explorative Biomarker substudy. The ALPHA trial was developed in collaboration with the Clinical Trials Research Unit at the University of Leeds with support from the UK Dermatology Clinical Trials Network (UK DCTN). The UK DCTN is grateful to the British Association of Dermatologists and the University of Nottingham for financial support of the Network. This research is also supported by the NIHR Leeds Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 142 - N° 3
P. 988 - septembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?